Dexamethasone acutely accelerates pleural fluid absorption in mice hydrothoraces

Abstract

This study assessed the effect of corticosteroid treatment in the clearance of hydrothoraces in mice. Twenty-four C57BL/6 mice were divided into four groups and were injected intrapleurally with 500 microL sterilized PBS-BSA 1% to create isosmotic hydrothoraces. Two groups served as control and two groups were treated with dexamethasone. The control groups received intraperitoneally PBS, while the corticosteroid treatment groups received dexamethasone (1 mg/kg), both 5 min after the induction of hydrothorax. Control and treated animals were sacrificed 2 and 4 h after the induction of hydrothorax, and pleural fluid volume was measured. The pleural fluid volume 2 and 4 h after the induction of hydrothoraces was significantly lower in the dexamethasone-treated group compared to the untreated group. The rate of pleural fluid absorption 2 and 4 h after the induction of hydrothoraces was significantly higher in the dexamethasone-treated groups. The present study demonstrated that dexamethasone accelerates pleural fluid absorption in induced isosmotic hydrothoraces in mice. This newly reported property of dexamethasone may partly account for the clinical observation of faster resolution of pleural effusions when corticosteroids are administered in patients with pleural effusions of certain etiologies.

Pleural Effusion as a Potential Complication of Foreign Body Reaction to Silicone Breast Implants: A Case Study

“…Corticosteroids can be an effective treatment option for pleural effusions resulting from inflammation in certain conditions, such as autoimmune diseases and post-cardiac injury syndrome. The anti-inflammatory properties of corticosteroids are believed to reduce pleural fluid production and accelerate its absorption rate, leading to faster resolution of the effusion [ 15 ]. Studies have reported successful clearance of pleural effusions in seven days to six weeks with prednisone doses of 20 to 30 mg/day.…”

Non‐steroidal Anti‐inflammatory Drugs and the Risk of Pneumonia Complications: A Systematic Review

“…It has been hypothesized that NSAIDs use may suppress natural immune processes through inhibition of cyclooxygenase activity and prostaglandin synthesis and in turn lead to phagocytosis and leukocyte activation 11, 20, 22 . Decreases in production of prostaglandins play a critical role in subsequently decreasing the permeability of the pleura, leading to increased pleural fluid and reduction in clearance of pathogens 11, 14, 23 . NSAIDs might also paradoxically increase inflammatory response within the lungs, as indicated by greater white blood cell migration, in particular, neutrophils 13, 14 .…”

Prehospital NSAIDs use prolong hospitalization in patients with pleuro-pulmonary infection

“…Additionally, NSAIDs induced increased white cell migration within the pleural cavity with a higher percentage of neutrophils present, indicating the initiation of an inflammatory response in the remaining hydrothorax [29,31]. It is highly likely that NSAIDs have a similar effect in parapneumonic effusions; their effects on ENaC and Na þ ÀK þ ATPase decrease the absorption rate of the pleural fluid and pathogen clearance allowing potential pathogens to lead to complicated pleural effusion [32]. However, the exact underlying pathophysiological mechanism remains unclear so far.…”